Benzinga | Nov 12, 2020 04:04PM EST

Bionano Genomics Q3 Sales $2.20M Beat $2.07M Estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $2.20 million which beat the analyst consensus estimate of $2.07 million by 6.09 percent. This is a 33.72 percent decrease over sales of $3.31 million the same period last year.